SENSEX NIFTY

Ranbaxy Laboratories

Apr 04, 2016 at 19:50 | Source: PTI
The Supreme Court today directed the government to reply in two weeks on a plea seeking cancellation of licence issued to Ranbaxy Laboratories Ltd forallegedly selling substandard drugs in India.
Mar 07, 2016 at 12:26 | Source: Reuters
Three years ago, Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures.
Jan 22, 2016 at 19:05 | Source: PTI
Last year in September, Sun Pharma and Strides Shasun (then Strides Arcolab) had inked a pact related to Ranbaxy's 'Solus' and 'Solus Care' divisions operating in the central nervous system (CNS) segment in India.
Oct 28, 2015 at 20:15 | Source: PTI
As per the information available on the USFDA website, Ohm Laboratories Inc, a unit of Ranbaxy Laboratories, which the company acquired last year, is recalling 10,85,095 boxes for being "Superpotent Drug: Out Of Specification".
Oct 11, 2015 at 11:27 | Source: PTI
The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.
Oct 09, 2015 at 08:36 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has withdrawn its appeal in the lawsuit filed by erstwhile Ranbaxy Laboratories Limited (Ranbaxy) in November 2014 in a US District Court against U.S. Food and Drug Administration (FDA).
Sep 24, 2015 at 16:42 | Source: CNBC-TV18
Prakash Diwan of prakashdiwan.in is of the view that Lupin may test Rs 2600-2700.
Sep 24, 2015 at 13:25 | Source: CNBC-TV18
Deepak Shenoy of capitalmind.in has a positive stance on Sun Pharmaceutical Industries and Strides Arcolab.
Sep 24, 2015 at 11:30 | Source: CNBC-TV18
Watch the interview of Deepak Shenoy of capitalmind.in with Latha Venkatesh and Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on the market, specific stocks and sectors.
Sep 23, 2015 at 14:11 | Source: PTI
Shivinder Mohan Singh (40), who is the co-founder of the healthcare chain will become the Non-Executive Vice-Chairman with effect from January 1, 2016, the company said in a statement.
Messages on Ranbaxy Laboratories »

hello1238

Platinum Member

469 Followers

Pantaloon Ret  

17.5 billion yen a year earlier. Daiichi Sankyo still expects full-year profit of 50 billion yen, the Tokyo-based drugmaker said in a statement today. Daiichi Sankyo, which owns 64 percent stake of India’s Ranbaxy Laboratories Ltd. (RBXY), accounts for the Indian unit’s earnings with a quarter lag

10.24 AM Jan 31st 2013

hello1238

Platinum Member

469 Followers

Ranbaxy Labs  

, from 17.5 billion yen a year earlier. Daiichi Sankyo still expects full-year profit of 50 billion yen, the Tokyo-based drugmaker said in a statement today. Daiichi Sankyo, which owns 64 percent stake of India’s Ranbaxy Laboratories Ltd. (RBXY), accounts for the Indian unit’s earnings with a quarter

10.23 AM Jan 31st 2013

BSE/NSE Announcer

Platinum Member

17374 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has informed BSE that a meeting of the Board of Directors of the Company will be held on February 26, 2013, inter alia, to consider and approve Audited Financial Results for the quarter and financial year ended December 31, 2012.

5.05 PM Jan 29th 2013

Market Statistician

Platinum Member

18759 Followers

Ranbaxy Labs  

At 15:14 hrs, Ranbaxy Laboratories was trading at Rs 455.20 up 0.84%, with a huge increase in its volume of shares traded. Till now over 274,298 shares were traded as compared to its 5-day average of 115,221 shares.

3.15 PM Jan 25th 2013

usha91

New Member

0 Follower

Services - Sector  

Ranbaxy Laboratories

3.39 PM Jan 23rd 2013

vikraj

Gold Member

14 Followers

Jupiter Bio  

into a Confidentiality Agreement with M/s. Ranbaxy Laboratories Ltd to discuss business alliance. 13 Apr 2007 Jupiter Bioscience - Outcome of Board Meeting Jupiter Bioscience Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 12, 2007, inter alia, has decided

6.32 PM Jan 17th 2013

Web Messenger

Platinum Member

367088 Followers

Ranbaxy Labs  

Source:Economic Times - In a chat with ET Now, Deepak Mohoni, Director, trendwatchindia.com, shares his views on Ranbaxy Laboratories Ltd. ET Now: What is your call on Ranbaxy Laboratories Ltd? Deepak Mohoni: Sell Ranbaxy Labs at a stop loss of Rs 494 and a target of 478. It is a pure day trade.

4.28 PM Jan 17th 2013

MMB Messenger

Platinum Member

373692 Followers

Ranbaxy Labs  

Ranbaxy Laboratories Limited has informed the Exchange that the Allotment Committee of Directors through Resolution by Circulation passed on December 21, 2012, allotted 440,000 Equity Shares of Rs.5 each for cash at par to Ranbaxy ESOP Trust (Trust), set up to administer Ranbaxy Employee Stock

1.20 PM Dec 21st 2012

Market Statistician

Platinum Member

18759 Followers

Ranbaxy Labs  

At 15:14 hrs, Ranbaxy Laboratories was trading at Rs 498.50 down 0.26%, with a huge increase in its volume of shares traded. Till now over 158,019 shares were traded as compared to its 5-day average of 69,355 shares.

3.15 PM Dec 14th 2012

Stock Advisor

Platinum Member

1147 Followers

Infosys  

Prabhudas Lilladher has come out with its report on "India strategy & top ideas". Infosys, ICICI Bank, Wipro, Cairn India, Power Grid Corporation, Dr.Reddy`s Laboratories, Adani Port & SEZ and Ranbaxy Laboratories are the stocks from large cap space

7.12 PM Dec 7th 2012

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.